STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News:
LinkMed’s (STO:LMED) portfolio company AbSorber has been granted a patent in the U.S. for an AB0 column that the company is developing to facilitate transplantations between individuals of different blood groups. The patent concerns a molecule that is being developed to adsorb antibodies and is a substance patent.
